New MS Drug Yields Mixed Results in Study

Relapse rates with daclizumab were lower than with a standard therapy, but side effects were greater

Source: HealthDay
Related MedlinePlus Pages: Medicines, Multiple Sclerosis via MedlinePlus Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1L8D9r1